{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T16:03:42Z","timestamp":1784045022573,"version":"3.55.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T00:00:00Z","timestamp":1779148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T00:00:00Z","timestamp":1783987200000},"content-version":"vor","delay-in-days":56,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Infective endocarditis (IE) remains a life-threatening infectious disease characterized by high morbidity and mortality despite substantial advances in diagnostic and therapeutic strategies (Eur Heart J 44:3948\u20134042, 2023, Eur J Clin Microbiol Infect Dis 44:1325\u20131333, 2025). Patients requiring intensive care unit (ICU) admission represent the most severe clinical spectrum of IE and continue to exhibit markedly elevated mortality rates (Klimik Derg 32:2\u2013116, Klimik Derg 36:216\u2013225, 2023). Early identification of mortality predictors in critically ill patients is essential for optimizing multidisciplinary management strategies and improving clinical outcomes (Eur Heart J 44:3948\u20134042, 2023, Open Forum Infect Dis 12:ofaf628, 2025). The aim of this study was to evaluate clinical and laboratory predictors of mortality among patients with infective endocarditis managed in the intensive care unit of a tertiary care center.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This retrospective cohort study included 59 adult patients with infective endocarditis who were managed in the intensive care unit of Ankara Bilkent City Hospital between 2022 and 2025. Demographic characteristics, comorbidities, microbiological findings, clinical severity scores, and laboratory parameters obtained at ICU admission were analyzed. The primary outcome was defined as in-ICU mortality. Receiver operating characteristic (ROC) curve analyses were performed to evaluate the predictive performance of the APACHE II score and the GCS. The AUCs of APACHE II and GCS were compared using DeLong\u2019s test for correlated ROC curves. Independent predictors of mortality were identified using multivariable logistic regression analysis. Time-to-event analysis was conducted using a Cox proportional hazards regression model to evaluate factors associated with mortality during ICU follow-up. Internal validation of the logistic regression and Cox proportional hazards models was performed using bootstrap resampling (10000 iterations).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The mean age of the cohort was 62.3 \u00b1 19.0 years. The overall in-ICU mortality rate was 52.5% (\n                      <jats:italic>n<\/jats:italic>\n                      = 31). ROC analysis demonstrated that the Glasgow Coma Scale showed a numerically higher discriminative performance compared with the APACHE II score (AUC: 0.758 vs. 0.717); however, the difference was not statistically significant. Multivariable logistic regression analysis identified lower GCS score (OR = 0.75,\n                      <jats:italic>p<\/jats:italic>\n                      = 0.017), presence of coronary artery disease (OR = 11.23,\n                      <jats:italic>p<\/jats:italic>\n                      = 0.008), fungal etiology (OR = 38.96,\n                      <jats:italic>p<\/jats:italic>\n                      = 0.008), and higher Nutritional Risk Screening (NRS) score (OR = 1.90,\n                      <jats:italic>p<\/jats:italic>\n                      = 0.043) as independent predictors of in-ICU mortality (Heart Fail Rev 30:1377\u20131395, 2025, Expert Consensus on the Prevention of Secondary Mucormycosis Following Respiratory Viral Infections, 2026). In Cox proportional hazards analysis, septic embolism (HR = 6.58,\n                      <jats:italic>p<\/jats:italic>\n                      = 0.047), coronary artery disease (HR = 3.23,\n                      <jats:italic>p<\/jats:italic>\n                      = 0.007), elevated total bilirubin (HR = 2.58,\n                      <jats:italic>p<\/jats:italic>\n                      = 0.006), increased creatinine (HR = 1.48,\n                      <jats:italic>p<\/jats:italic>\n                      = 0.006), elevated lactate dehydrogenase (HR = 1.001,\n                      <jats:italic>p<\/jats:italic>\n                      = 0.030), and lower albumin levels (HR = 0.92,\n                      <jats:italic>p<\/jats:italic>\n                      = 0.039) were independently associated with increased mortality hazard during ICU follow-up (Klimik Derg 32:2\u2013116, 2020, Heart Fail Rev 30:1377\u20131395, 2025).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Mortality among critically ill patients with infective endocarditis remains substantially high despite contemporary management strategies (Eur Heart J 44:3948\u20134042, 2023, Eur J Clin Microbiol Infect Dis 44:1325\u20131333, 2025). Neurological status assessed by GCS, nutritional risk evaluated by NRS, fungal etiology, and coronary artery disease emerged as key determinants of mortality risk, while septic embolism and markers of multiorgan dysfunction influenced mortality over time (Heart Fail Rev 30:1377\u20131395, 2025, Expert Consensus on the Prevention of Secondary Mucormycosis Following Respiratory Viral Infections, 2026). These findings highlight the importance of early risk stratification and multidisciplinary management and support the development of ICU-specific prognostic models to improve outcomes in this high-risk population (Eur Heart J 40:3222\u20133232, 2019, Open Forum Infect Dis 12:ofaf628, 2025).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Clinical trial number<\/jats:title>\n                    <jats:p>Not applicable.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12879-026-13338-y","type":"journal-article","created":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T08:46:03Z","timestamp":1779180363000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["ICU-specific determinants of mortality in critically ill patients with infective endocarditis"],"prefix":"10.1186","volume":"26","author":[{"given":"Dilek","family":"Kuzukiran Kocatas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Behiye Deniz","family":"Kosovali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nevzat Mehmet","family":"Mutlu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunal","family":"Bilek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,19]]},"reference":[{"issue":"39","key":"13338_CR1","doi-asserted-by":"publisher","first-page":"3948","DOI":"10.1093\/eurheartj\/ehad193","volume":"44","author":"V Delgado","year":"2023","unstructured":"Delgado V, Ajmone Marsan N, de Waha S, et al. 2023 ESC guidelines for the management of infective endocarditis. Eur Heart J. 2023;44(39):3948\u20134042. https:\/\/doi.org\/10.1093\/eurheartj\/ehad193.","journal-title":"Eur Heart J"},{"issue":"8","key":"13338_CR2","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1007\/s10096-025-05095-8","volume":"44","author":"EM Saricaoglu","year":"2025","unstructured":"Saricaoglu EM, Yilmaz M, et al. Epidemiological, clinical and microbiological aspects of infective endocarditis in T\u00fcrkiye. Eur J Clin Microbiol Infect Dis. 2025;44(8):1325\u201333. https:\/\/doi.org\/10.1007\/s10096-025-05095-8.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"Suppl 1","key":"13338_CR3","first-page":"2","volume":"32","author":"S \u015eim\u015fek-Yavuz","year":"2020","unstructured":"\u015eim\u015fek-Yavuz S, et al. Diagnosis, treatment and prevention of infective endocarditis: national consensus report. Klimik Derg. 2020;32(Suppl 1):2\u2013116.","journal-title":"Klimik Derg"},{"issue":"3","key":"13338_CR4","doi-asserted-by":"publisher","first-page":"216","DOI":"10.36519\/kd.2023.4412","volume":"36","author":"N Sar\u0131","year":"2023","unstructured":"Sar\u0131 N, et al. Three-year infective endocarditis team experience in a university hospital. Klimik Derg. 2023;36(3):216\u201325. https:\/\/doi.org\/10.36519\/kd.2023.4412.","journal-title":"Klimik Derg"},{"issue":"2","key":"13338_CR5","doi-asserted-by":"publisher","first-page":"46","DOI":"10.5152\/kd.2015.11","volume":"28","author":"S \u015eim\u015fek-Yavuz","year":"2015","unstructured":"\u015eim\u015fek-Yavuz S. Infective endocarditis: current perspectives. Klimik Derg. 2015;28(2):46\u201367.","journal-title":"Klimik Derg"},{"issue":"44","key":"13338_CR6","doi-asserted-by":"publisher","first-page":"3075","DOI":"10.1093\/eurheartj\/ehv319","volume":"36","author":"G Habib","year":"2015","unstructured":"Habib G, Lancellotti P, Antunes MJ, et al. 2015 ESC guidelines for the management of infective endocarditis. Eur Heart J. 2015;36(44):3075\u2013128. https:\/\/doi.org\/10.1093\/eurheartj\/ehv319.","journal-title":"Eur Heart J"},{"key":"13338_CR7","doi-asserted-by":"publisher","first-page":"105494","DOI":"10.1016\/j.nurpra.2025.105494","volume":"21","author":"L Brien","year":"2025","unstructured":"Brien L, et al. Current diagnosis and management of infective endocarditis in adults. J Nurse Pract. 2025;21:105494. https:\/\/doi.org\/10.1016\/j.nurpra.2025.105494.","journal-title":"J Nurse Pract"},{"key":"13338_CR8","doi-asserted-by":"publisher","first-page":"2046","DOI":"10.1007\/s00134-004-2420-7","volume":"30","author":"B Mourvillier","year":"2004","unstructured":"Mourvillier B, Trouillet JL, Timsit JF, et al. Infective endocarditis in the intensive care unit: clinical spectrum and prognostic factors in 228 consecutive patients. Intensive Care Med. 2004;30:2046\u201352. https:\/\/doi.org\/10.1007\/s00134-004-2420-7.","journal-title":"Intensive Care Med"},{"key":"13338_CR9","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1007\/s10741-025-10556-5","volume":"30","author":"RB P\u00eer\u00eeianu-Masgras","year":"2025","unstructured":"P\u00eer\u00eeianu-Masgras RB, et al. Infective endocarditis complicated by shock: a systematic review and meta-analysis. Heart Fail Rev. 2025;30:1377\u201395. https:\/\/doi.org\/10.1007\/s10741-025-10556-5.","journal-title":"Heart Fail Rev"},{"issue":"39","key":"13338_CR10","doi-asserted-by":"publisher","first-page":"3222","DOI":"10.1093\/eurheartj\/ehz620","volume":"40","author":"G Habib","year":"2019","unstructured":"Habib G, Erba PA, Iung B, et al. Clinical presentation, aetiology and outcome of infective endocarditis: results of the ESC-EORP EURO-ENDO registry. Eur Heart J. 2019;40(39):3222\u201332. https:\/\/doi.org\/10.1093\/eurheartj\/ehz620.","journal-title":"Eur Heart J"},{"key":"13338_CR11","doi-asserted-by":"publisher","unstructured":"Dong H, Song M, Sun J, et al. Comprehensive review on candidemia: epidemiology, diagnosis, treatment, and future directions. iFungi. 2026. https:\/\/doi.org\/10.26599\/iFungi.2026.9670005.","DOI":"10.26599\/iFungi.2026.9670005"},{"key":"13338_CR12","doi-asserted-by":"publisher","unstructured":"Yuan C, Gao R, Lu L. Aspergillus and aspergillosis in the post-pandemic Era. iFungi. 2026. https:\/\/doi.org\/10.26599\/iFungi.2026.9670006.","DOI":"10.26599\/iFungi.2026.9670006"},{"key":"13338_CR13","doi-asserted-by":"publisher","unstructured":"Qu J, Liu X, Quan M, et al. Expert consensus on the prevention of secondary mucormycosis following respiratory viral infections. iFungi. 2026. https:\/\/doi.org\/10.26599\/iFungi.2026.9670007.","DOI":"10.26599\/iFungi.2026.9670007"},{"issue":"5","key":"13338_CR14","doi-asserted-by":"publisher","first-page":"e0300322","DOI":"10.1371\/journal.pone.0300322","volume":"19","author":"H Tesfay","year":"2024","unstructured":"Tesfay H, et al. Predictors of infective endocarditis-associated in-hospital mortality in Ethiopia. PLoS ONE. 2024;19(5):e0300322. https:\/\/doi.org\/10.1371\/journal.pone.0300322.","journal-title":"PLoS ONE"},{"key":"13338_CR15","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1186\/s12879-024-10044-3","volume":"24","author":"S Huang","year":"2024","unstructured":"Huang S, et al. Pathogenic spectrum and risk factors for poor prognosis in surgical patients with infective endocarditis. BMC Infect Dis. 2024;24:1440. https:\/\/doi.org\/10.1186\/s12879-024-10044-3.","journal-title":"BMC Infect Dis"},{"issue":"2","key":"13338_CR16","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.jmii.2024.01.008","volume":"58","author":"CY Wang","year":"2025","unstructured":"Wang CY, et al. Clinical characteristics and prognostic factors of infective endocarditis in hemodialysis patients. J Microbiol Immunol Infect. 2025;58(2):337\u201345. https:\/\/doi.org\/10.1016\/j.jmii.2024.01.008.","journal-title":"J Microbiol Immunol Infect"},{"issue":"10","key":"13338_CR17","doi-asserted-by":"publisher","first-page":"ofaf628","DOI":"10.1093\/ofid\/ofaf628","volume":"12","author":"A Stavropoulou","year":"2025","unstructured":"Stavropoulou A, et al. Timing of antimicrobial treatment initiation and its impact on outcomes of patients with suspected infective endocarditis. Open Forum Infect Dis. 2025;12(10):ofaf628. https:\/\/doi.org\/10.1093\/ofid\/ofaf628.","journal-title":"Open Forum Infect Dis"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-026-13338-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-13338-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-13338-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T15:03:40Z","timestamp":1784041420000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-026-13338-y"}},"subtitle":["Mortality predictors in ICU patients with infective endocarditis"],"short-title":[],"issued":{"date-parts":[[2026,5,19]]},"references-count":17,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["13338"],"URL":"https:\/\/doi.org\/10.1186\/s12879-026-13338-y","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,19]]},"assertion":[{"value":"15 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the Institutional Ethics Committee of Ankara Bilkent City Hospital (Approval No: TABED 1-25-1406) and conducted in accordance with the Declaration of Helsinki. Due to the retrospective design, informed consent was waived.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1322"}}